Literature DB >> 475366

Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

H Lode, R Stahlmann, P Koeppe.   

Abstract

In a randomized crossover study, the pharmacokinetics of three new cephalosporin antibiotics, cefaclor, cefadroxil, and CGP 9000, in comparison to cephalexin, were determined after oral administration, by capsules, of 1,000 mg on an empty stomach in 12 normal subjects. Serum concentrations were measured during a period of 8 h, and urine recovery was measured during 24 h. The significant parameters of bioavailability of an orally administered substance were determined. The maximal serum concentrations (y(max)) for cephalexin, cefaclor, cefadroxil, and CGP 9000 (in milligrams per liter) were: 38.8 +/- 8.1; 34.6 +/- 7.8; 33.0 +/- 5.4; and 23.3 +/- 7.3, respectively. The areas under the curve (in hours x milligrams per liter) were: 93.0 +/- 14.8; 74.5 +/- 9.9; 70.1 +/- 9.0; and 108.5 +/- 18.4, respectively. In a further crossover study with six subjects, 1,000 mg of cephalexin and of cefadroxil were given during a standard breakfast. The y(max) of cephalexin decreased to 23.1 +/- 6.6 mg/liter, in contrast to cefadroxil, with an unchanged y(max) of 32.7 +/- 3.4 mg/liter.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 475366      PMCID: PMC352777          DOI: 10.1128/AAC.16.1.1

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Studies on the relationship of tissue fluid and blood levels of penicillin.

Authors:  L WEINSTEIN; G K DAIKOS; T S PERRIN
Journal:  J Lab Clin Med       Date:  1951-11

2.  Stability and blood level determinations of cefaclor, a new oral cephalosporin antibiotic.

Authors:  M A Foglesong; J W Lamb; J V Dietz
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

3.  Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.

Authors:  N J Bill; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

4.  Kinetics of tissue penetration. Are high plasma peak concentrations or sustained levels preferable for effective antibiotic therapy?

Authors:  T Bergan
Journal:  Scand J Infect Dis Suppl       Date:  1978

5.  Pharmacokinetics of cefaclor and cephalexin: dosage nomograms for impaired renal function.

Authors:  D A Spyker; B L Thomas; M A Sande; W K Bolton
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

6.  Pharmacology of cefaclor in normal volunteers and patients with renal failure.

Authors:  J Santoro; B N Agarwal; R Martinelli; N Wenger; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

7.  Clinical pharmacology of cefadroxil in infants and children.

Authors:  C M Ginsburg; G H McCracken; J C Clahsen; M L Thomas
Journal:  Antimicrob Agents Chemother       Date:  1978-05       Impact factor: 5.191

8.  Cefaclor: in vitro spectrum of activity and beta-lactamase stability.

Authors:  H C Neu; K P Fu
Journal:  Antimicrob Agents Chemother       Date:  1978-04       Impact factor: 5.191

9.  Pharmacokinetics of cefaclor in infants and children.

Authors:  G H McCracken; C M Ginsburg; J C Clahsen; M L Thomas
Journal:  J Antimicrob Chemother       Date:  1978-11       Impact factor: 5.790

10.  Pharmacological evaluation of cefaclor in volunteers.

Authors:  G R Hodges; C Liu; D R Hinthorn; J L Harms; D L Dworzack
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

View more
  32 in total

1.  The effect of four different types of food on the bioavailability of cefaclor.

Authors:  S Karim; T Ahmed; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2003 Jul-Sep       Impact factor: 2.441

2.  Pharmacokinetics of roxithromycin and influence of H2-blockers and antacids on gastrointestinal absorption.

Authors:  M Boeckh; H Lode; G Höffken; S Daeschlein; P Koeppe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

3.  Comparative effect of different types of food on the bioavailability of cefaclor extended release tablet.

Authors:  B A H Khan; T Ahmed; S Karim; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

4.  The effect of staggered administration of zinc sulfate on the pharmacokinetics of oral cephalexin.

Authors:  Yi Ding; Yan-Yan Jia; Fan Li; Wen-Xing Liu; Cheng-Tao Lu; Yan-Rong Zhu; Jing Yang; Li-Kun Ding; Lin Yang; Ai-Dong Wen
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

5.  The effect of four different types of diet on the bioavailability of loracarbef.

Authors:  A T Bapujee; T Singh; T Ahmed; T Monif; N Saha; P L Sharma
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Oct-Dec       Impact factor: 2.441

6.  Phase I study of multiple-dose cefprozil and comparison with cefaclor.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; R R Martin; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

7.  Comparison of cefprozil and cefaclor pharmacokinetics and tissue penetration.

Authors:  R H Barbhaiya; U A Shukla; C R Gleason; W C Shyu; R B Wilber; K A Pittman
Journal:  Antimicrob Agents Chemother       Date:  1990-06       Impact factor: 5.191

8.  Multiple-dose pharmacokinetics of cefprozil and its impact on intestinal flora of volunteers.

Authors:  H Lode; C Müller; K Borner; C E Nord; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

9.  Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid.

Authors:  K M Deppermann; H Lode; G Höffken; G Tschink; C Kalz; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

Review 10.  Interethnic differences in pharmacokinetics of antibacterials.

Authors:  Danny Tsai; Janattul-Ain Jamal; Joshua S Davis; Jeffrey Lipman; Jason A Roberts
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.